ArticleBMC pregnancy and childbirth2026
Blood pressure trajectory during late pregnancy and the risk of severe preeclampsia-related complications: a retrospective cohort study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundIn non-pregnant populations, blood pressure variability is an independent predictor of adverse cardiovascular outcomes. However, its prognostic value for stratifying risk among women who have already developed hypertensive disorders of pregnancy (HDP) remains unclear. This study aimed to evaluate the association between blood pressure variability in late pregnancy and the risk of severe adverse outcomes in women with HDP.
methodsThis was a retrospective cohort study of 3,118 pregnant women with HDP at a tertiary care center from 2018 to 2023. Blood pressure variability for systolic, diastolic, pulse pressure, and mean arterial pressure (MAP) was calculated from measurements after 24 weeks of gestation. Exposure was defined as high variability (≥ 90th percentile). The primary outcome was a composite of severe preeclampsia-related complications. The secondary outcome was HDP delivered an infant with low birth weight (LBW) (< 2500 g). Associations were assessed using overlap weighting-adjusted logistic regression to control for age, pre-pregnancy body mass index (BMI), and history of chronic hypertension.
resultsHigh blood pressure variability was significantly associated with an increased risk of the primary outcome, with the strongest association observed for MAP variability (adjusted odds ratio 4.25, 95% confidence interval 3.285.514), followed by diastolic, systolic, and pulse pressure variability. Similarly, high variability was associated with the secondary outcome of HDP complicated with LBW (MAP: OR 2.51, 95% CI 1.65–3.82). A dose-response analysis demonstrated a near-linear increase in risk with increasing variability thresholds. Results were robust across multiple sensitivity analyses, including propensity score matching.
conclusionsAmong women with HDP, high blood pressure variability in late pregnancy, particularly in MAP, is a strong, independent risk marker for severe adverse outcomes. Assessing blood pressure variability may enhance risk stratification and identify candidates for more intensive monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.